Optimal duration of dual antiplatelet therapy for coronary artery disease-Reference-Cited by-同舟云学术

Optimal duration of dual antiplatelet therapy for coronary artery disease

Published:2018-04-30 Issue:6 Volume:26 Page:321-333
ISSN:1568-5888
Container-title:Netherlands Heart Journal
language:en
Short-container-title:Neth Heart J

Author:

Kikkert W. J.,Damman P.

Funder

AstraZeneca Schweiz

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

http://link.springer.com/article/10.1007/s12471-018-1113-5/fulltext.html

Reference43 articles.

1. Population Division. Department of Economic and Social Affairs. United Nations. Revision of World Population Prospects. https://esa.un.org/unpd/wpp/ . Accessed 13.10.2017

2. Colombo A, Hall P, Nakamura S, et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation. 1995;91:1676–88.

3. McFadden EP, Stabile E, Regar E, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet. 2004;364:1519–21.

4. Dangas GD, Serruys PW, Kereiakes DJ, et al. Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3‑year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions). JACC Cardiovasc Interv. 2013;6:914–22.

5. Kikkert WJ, Hoebers LP, Damman P, et al. Recurrent myocardial infarction after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Am J Cardiol. 2014;113:229–35.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inter‐relationships between cardiovascular, renal and metabolic diseases: Underlying evidence and implications for integrated interdisciplinary care and management;Diabetes, Obesity and Metabolism;2024-02-08

2. Non-vitamin-K-antagonist oral anticoagulants (NOACs) after acute myocardial infarction: a network meta-analysis;Cochrane Database of Systematic Reviews;2024-01-24

3. Factors associated with early, late, and very late stent thrombosis among patients with acute coronary syndrome undergoing coronary stent placement: analysis from the ATLAS ACS 2-TIMI 51 trial;Frontiers in Cardiovascular Medicine;2024-01-08

4. Individualization of Duration of Dual Antiplatelet Therapy after Coronary Stenting: A Comprehensive, Evidence-Based Review;Journal of Clinical Medicine;2023-11-17

5. Structural and temporal dynamics analysis on drug-eluting stents: History, research hotspots and emerging trends;Bioactive Materials;2023-05